Edition:
United Kingdom

Altimmune Inc (ALT.OQ)

ALT.OQ on NASDAQ Stock Exchange Global Market

1.87USD
17 Jan 2018
Change (% chg)

$-0.03 (-1.58%)
Prev Close
$1.90
Open
$1.88
Day's High
$1.92
Day's Low
$1.87
Volume
16,853
Avg. Vol
30,395
52-wk High
$35.00
52-wk Low
$1.51

Select another date:

Wed, Jan 3 2018

BRIEF-Altimmune Elects Mitchel Sayare As Chairman Of Its Board

* ALTIMMUNE ELECTS MITCHEL SAYARE, PH.D. AS CHAIRMAN OF ITS BOARD OF DIRECTORS

BRIEF-Altimmune reports Q3 loss per share $2.05

* Altimmune announces third quarter 2017 financial results and provides corporate update

BRIEF-Altimmune to provide corporate update at Rodman & Renshaw global investment conference

* Altimmune to provide corporate update at the Rodman & Renshaw global investment conference Source text for Eikon: Further company coverage:

BRIEF-Altimmune submits investigational new drug application for Nasovax for phase 2 trial preparation

* Altimmune submits investigational new drug application for Nasovax in preparation for Phase 2 trial

BRIEF-Altimmune announces $14.7 million Series B preferred stock offering

* Altimmune announces $14.7 million Series B preferred stock offering

BRIEF-Altimmune posts Q2 loss of $0.26 per share

* Altimmune announces second quarter 2017 financial results and provides corporate update

Select another date: